Coverage
-
December 12, 2017
A Georgia federal jury on Monday sided with the U.S. Securities and Exchange Commission and found that medical device maker Revolutions Medical Corp. and its top executive issued false statements to pump up its stock price.
1 other articles on this case.
View all »